Dynamic Technology Lab Private Ltd Invests $93,000 in Definitive Healthcare Corp. (NASDAQ:DH)

Dynamic Technology Lab Private Ltd bought a new position in Definitive Healthcare Corp. (NASDAQ:DH) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 20,738 shares of the company’s stock, valued at approximately $93,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Massachusetts Financial Services Co. MA boosted its stake in Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after purchasing an additional 1,626,813 shares in the last quarter. 272 Capital LP bought a new position in Definitive Healthcare in the 2nd quarter worth about $3,480,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in Definitive Healthcare in the 3rd quarter worth about $512,000. Vanguard Group Inc. boosted its stake in Definitive Healthcare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after purchasing an additional 67,068 shares in the last quarter. Finally, Boston Partners bought a new position in Definitive Healthcare in the 1st quarter worth about $550,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on DH shares. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research note on Friday, August 9th. BTIG Research assumed coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. Barclays decreased their target price on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. Finally, Morgan Stanley dropped their target price on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 6th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Price Performance

Shares of DH opened at $4.67 on Wednesday. The firm has a market cap of $539.48 million, a price-to-earnings ratio of -1.51, a PEG ratio of 3.50 and a beta of 1.40. The stock has a 50 day moving average of $4.37 and a 200-day moving average of $4.77. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a 52 week low of $3.19 and a 52 week high of $10.62.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.